Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Jersey Health Reporter.
Press releases published on August 28, 2025
Dr. Eugenie Brunner Celebrates 20 Year Milestone With Top Doctor Honor
EIN Presswire
·
August 28, 2025
Princeton facial plastic surgeon receives dual Castle Connolly honors for 2025, marking two decades of recognition for surgical excellence and innovation. PRINCETON, NJ, UNITED STATES, August 28, 2025 /EINPresswire.com/ -- Dr. Eugenie Brunner has …
Dr. Gbolahan Okubadejo Now Offering Comprehensive Wellness For NJ Patients
EIN Presswire
·
August 28, 2025
NJ Top Docs has reviewed and approved Gbolahan Okubadejo, MD, FAAOS of The Institute for Comprehensive Spine Care based on merit for 2025. ENGLEWOOD, NJ, UNITED STATES, August 28, 2025 /EINPresswire.com/ -- NJ Top Docs has reviewed and approved Gbolahan …
Olleyes, Inc. Expands VisuALL Virtual Reality Platform With Breakthrough Stereopsis Test
EIN Presswire
·
August 28, 2025
Olleyes announces the launch of a Stereopsis Test in its VisuALL Platform. This new test measures patients' binocular vision and assesses their depth perception SUMMIT, NJ, UNITED STATES, August 28, 2025 /EINPresswire.com/ -- Olleyes, Inc., a leader in …
Picard Medical, Inc. Announces Pricing of $17 Million Initial Public Offering
GlobeNewswire
·
August 28, 2025
TUCSON, Ariz., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (“Picard” or the “Company”), a medical technology company that manufactures and sells the only total artificial heart (the “SynCardia Total Artificial Heart”, or “STAH”) approved by the …
Eagle Pharmaceuticals to Appoint Abhinav Jain to its Board of Directors
GlobeNewswire
·
August 28, 2025
WOODCLIFF LAKE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that it has agreed to appoint Abhinav “Abi” Jain as an independent member of its Board of Directors, subject to …
Dr. James C. Wittig To Chair 113th Clinical Orthopaedic Society Annual Meeting
EIN Presswire
·
August 28, 2025
Top Orthopedic Oncologist and Medical Industry Leader, James C. Wittig, MD to Deliver Opening Address alongside Dr. Afshin Razi, President COS MORRISTOWN, NJ, UNITED STATES, August 28, 2025 /EINPresswire.com/ -- Mandala Medical Group today announced …
Rakovina Therapeutics Announces Three-Month Q2 ended June 30, 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 28, 2025
VANCOUVER, British Columbia, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies through AI-powered drug discovery, today announced its …
UPDATE - Carlsmed® Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 28, 2025
Q2’25 revenue of $12.1 million, 99% YOY growth Full year revenue guidance of $45.5M - $47.5M CARLSBAD, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled …
Privia Health ACOs Delivered $233+ Million in Total Savings in the 2024 Performance Year of Medicare Shared Savings Program, a 32% Year-over-Year Increase
GlobeNewswire
·
August 28, 2025
– Mid-Atlantic ACO Realized Highest Savings Rate of All ACOs with 40,000+ Attributed Lives – Company Increases Adjusted EBITDA Guidance for Full-Year 2025 ARLINGTON, Va., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today …
Cascade Prodrug Inc. Appoints Industry Veterans Manuel (Manny) Litchman and Andres Gutierrez to Board of Directors
GlobeNewswire
·
August 28, 2025
EUGENE, Ore., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cascade Prodrug, Inc. (“Cascade”), a biotechnology company focused on advancing novel Hypoxia Activated Therapies in oncology, today announced the appointment of Manuel (Manny) Litchman, M.D. and Andres …
Kane Biotech Announces Second Quarter 2025 Financial Results
GlobeNewswire
·
August 28, 2025
WINNIPEG, Manitoba, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announced its second quarter 2025 financial results. Second Quarter 2025 Financial Highlights (Comparatives exclude …
Medirom’s “REMONY” Certified by MLIT as a Fatigue-Driving Prevention Device
GlobeNewswire
·
August 28, 2025
TOKYO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”, “we” or “us”) announces that its “REMONY for Driver” remote health management system, developed by its subsidiary MEDIROM MOTHER Labs Inc. (“MOTHER Labs …
LeMaitre to Participate at Upcoming Investor Conferences in September
GlobeNewswire
·
August 28, 2025
BURLINGTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in four upcoming investor conferences. 2025 Wells Fargo Healthcare Conference Wednesday, September 3, 2025 Encore …
Globus Medical, Inc. Secures Jury Verdict in Delaware Patent Litigation Against Life Spine, Inc.
GlobeNewswire
·
August 28, 2025
AUDUBON, Pa., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, announced that a Delaware jury has returned a verdict in favor of Globus in its patent infringement litigation against Life …
Community Mental Health Association of Michigan Praises Lawsuit Filed to Stop PIHP Bid Process
GlobeNewswire
·
August 28, 2025
LANSING, Mich., Aug. 28, 2025 (GLOBE NEWSWIRE) -- The Community Mental Health Association of Michigan (CMHA) released the following statement today from its CEO Robert Sheehan to applaud the public behavioral health entities who filed suit to stop the bid …
Surrozen to Present at Upcoming Healthcare Investor Conference
GlobeNewswire
·
August 28, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway, with a focus on severe eye …
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 28, 2025
SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September
GlobeNewswire
·
August 28, 2025
CAMBRIDGE, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, …
Cardiff Oncology to Participate in Three Upcoming Investor Conferences
GlobeNewswire
·
August 28, 2025
SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will …
Neuphoria Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
August 28, 2025
BURLINGTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“Neuphoria” or the “Company”), a clinical-stage biotechnology company developing impactful treatments for neuropsychiatric disorders, today announced that …